Caution before fractionating COVID-19 vaccines
Nat Med
.
2021 Nov;27(11):1856-1857.
doi: 10.1038/s41591-021-01534-z.
Authors
Annelies Wilder-Smith
1
2
3
,
Shalini Desai
4
,
Alejandro Cravioto
5
,
Hanna Nohynek
6
,
Joachim Hombach
4
Affiliations
1
Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland. wildersmitha@who.int.
2
Institute of Social and Preventive Medicine, University of Berne, Berne, Switzerland. wildersmitha@who.int.
3
Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany. wildersmitha@who.int.
4
Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
5
Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
6
Department of Health Security at the Finnish Institute for Health and Welfare, Helsinki, Finland.
PMID:
34552264
DOI:
10.1038/s41591-021-01534-z
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
COVID-19 Vaccines*
COVID-19*
Humans
SARS-CoV-2
Substances
COVID-19 Vaccines
Grants and funding
001/WHO_/World Health Organization/International